Skip to content

Clinical trials

Phase 3 Proteinuria trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Proteinuria Phase: Phase 3 Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20035
20061
20074
20081
20092
20101
20111
20122
20133
20142
20151
20161
20172
20184
20201
20213
20222
20231
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27
Recruiting6
Terminated4
Unknown status3
Not yet recruiting2
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Bayer3
Alexion Pharmaceuticals, Inc.2
Chiesi Farmaceutici S.p.A.2
Seoul National University Hospital2
A. Manzoni Hospital1
AO GENERIUM1
Albert Einstein College of Medicine1
AstraZeneca1
Biohaven Therapeutics Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Proteinuria45
Glomerulonephritis, IGA12
Renal Insufficiency, Chronic8
Kidney Diseases6
Diabetic Nephropathies4
Glomerulonephritis4
Albuminuria3
Fabry Disease3
Hypertension3
Diabetes Mellitus2

Trials

Showing 76 to 45 of 45. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.